News and Events
Physicians’ misunderstanding of genetic test results may hamper mastectomy decisions for breast cancer patients
A recent survey of over 2,000 women newly diagnosed with breast cancer found that half of those who undergo bilateral mastectomy after genetic testing don’t actually have mutations known to confer increased risk of additional cancers.
The Forbes Institute for Cancer Discovery at the University of Michigan has announced its first round of grant recipients, with $500,000 earmarked to undertake high-risk, high-reward initiatives with the potential to drive new advances in cancer research.
Health coalition forms National Lung Cancer Roundtable to increase screening, reduce lung cancer deaths
The American Cancer Society and a coalition of leading professional, government and non-governmental organizations are coming together to form the National Lung Cancer Roundtable to accelerate the nation’s efforts to reduce mortality from lung cancer.
When small-molecule inhibitors proved elusive, researchers developed a novel strategy: Using large molecule peptides to target a common prostate cancer driver. It may provide a path for developing new therapies against a challenging target.